We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FEMSelect’s EnPlace meshless pelvic floor ligament fixation system had positive results in a four-year prospective follow-up study of 14 patients, the company said in a Tuesday statement. Read More
An experimental radiotracer known as [18F]flurpiridaz has met its two primary endpoints of exceeding a 60 percent threshold for both sensitivity and specificity in detecting coronary artery disease (CAD), according to the sponsors, GE Healthcare and Lantheus. Read More
Manufacturers ready to establish a risk-based framework for computer software assurance throughout the software’s lifecycle now have a clearer place to start. Read More
OssView, medical diagnostic software that calculates bone microstructural deterioration, has received Breakthrough Device Designation from the FDA, according to developer CurveBeam AI of Hatfield, Penn. The designation will give the investigational software a prioritized 510(k) application review. Read More
Political pressure and internet-bred conspiracy theories have eroded one of the FDA’s prime functions — the communication of scientific truth, FDA Commissioner Robert Califf said at the annual meeting of the Regulatory Affairs Professional Society (RAPS) taking place in Phoenix, Ariz. this week. Read More
The EU released last week a working draft of a manual to help devicemakers understand where the line between a device and another type of product falls and how devices are classified under the Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). Read More
In two pivotal phase 3 trials, data showed that Glaukos’s combination product iDose TR succeeded in reducing intraocular pressure (IOP) safely. Read More
The FDA has issued a final guidance for laboratories and manufacturers on its policy for reviewing emergency use authorization of tests to diagnose monkeypox, bypassing the draft guidance stage. Read More